These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 8734355)
21. A mathematical model of vaccination against HIV to prevent the development of AIDS. Nowak MA; McLean AR Proc Biol Sci; 1991 Nov; 246(1316):141-6. PubMed ID: 1685238 [TBL] [Abstract][Full Text] [Related]
24. Protection against chronic infection and AIDS by an HIV envelope peptide-cocktail vaccine in a pathogenic SHIV-rhesus model. Nehete PN; Chitta S; Hossain MM; Hill L; Bernacky BJ; Baze W; Arlinghaus RB; Sastry KJ Vaccine; 2001 Dec; 20(5-6):813-25. PubMed ID: 11738745 [TBL] [Abstract][Full Text] [Related]
25. Development of prophylactic AIDS vaccines: the current state of affairs. Hanke T Curr Opin Mol Ther; 2003 Feb; 5(1):25-32. PubMed ID: 12669467 [TBL] [Abstract][Full Text] [Related]
26. Systems serology for evaluation of HIV vaccine trials. Ackerman ME; Barouch DH; Alter G Immunol Rev; 2017 Jan; 275(1):262-270. PubMed ID: 28133810 [TBL] [Abstract][Full Text] [Related]
27. HIV/AIDS treatment and HIV vaccines for Africa. Weidle PJ; Mastro TD; Grant AD; Nkengasong J; Macharia D Lancet; 2002 Jun; 359(9325):2261-7. PubMed ID: 12103304 [TBL] [Abstract][Full Text] [Related]
28. AIDS vaccine development: the long and winding road. Garber DA; Feinberg MB AIDS Rev; 2003; 5(3):131-9. PubMed ID: 14598562 [TBL] [Abstract][Full Text] [Related]
29. Determining the immune mechanisms of protection from AIDS: correlates of immunity and the development of syngeneic macaques. Kent SJ; Ada GL; Hayes E; Lewis IM Immunol Rev; 2001 Oct; 183():94-108. PubMed ID: 11782250 [TBL] [Abstract][Full Text] [Related]
32. The prospects for and pathways toward a vaccine for AIDS. Francis DP; Petricciani JC N Engl J Med; 1985 Dec; 313(25):1586-90. PubMed ID: 2999596 [TBL] [Abstract][Full Text] [Related]
33. DNA vaccination for HIV-1 and SIV. Barouch DH; Letvin NL Intervirology; 2000; 43(4-6):282-7. PubMed ID: 11251383 [TBL] [Abstract][Full Text] [Related]
34. Macaque models for AIDS vaccine development. Johnson RP Curr Opin Immunol; 1996 Aug; 8(4):554-60. PubMed ID: 8794019 [TBL] [Abstract][Full Text] [Related]
35. Immunology and the elusive AIDS vaccine. Virgin HW; Walker BD Nature; 2010 Mar; 464(7286):224-31. PubMed ID: 20220841 [TBL] [Abstract][Full Text] [Related]
36. AIDS vaccine: present problems and future perspectives. Ennen J; Norley SG; Kurth R Int J Clin Lab Res; 1992; 22(4):206-10. PubMed ID: 1467536 [TBL] [Abstract][Full Text] [Related]
37. Willingness to participate in AIDS vaccine trials among high-risk populations in northern Thailand. Celentano DD; Beyrer C; Natpratan C; Eiumtrakul S; Sussman L; Renzullo PO; Khamboonruang C; Nelson KE AIDS; 1995 Sep; 9(9):1079-83. PubMed ID: 8527082 [TBL] [Abstract][Full Text] [Related]
38. A new approach to AIDS research and prevention: the use of gene-mutated HIV-1/SIV chimeric viruses for anti-HIV-1 live-attenuated vaccines. Haga T; Kuwata T; Ui M; Igarashi T; Miyazaki Y; Hayami M Microbiol Immunol; 1998; 42(4):245-51. PubMed ID: 9623910 [TBL] [Abstract][Full Text] [Related]
39. Progress towards development of an HIV vaccine: report of the AIDS Vaccine 2009 Conference. Ross AL; BrĂ¥ve A; Scarlatti G; Manrique A; Buonaguro L Lancet Infect Dis; 2010 May; 10(5):305-16. PubMed ID: 20417413 [TBL] [Abstract][Full Text] [Related]
40. Development of a vaccine for the prevention of AIDS, a critical appraisal. Karzon DT; Bolognesi DP; Koff WC Vaccine; 1992; 10(14):1039-52. PubMed ID: 1281948 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]